Key result
In symptomatic patients without flow-limiting obstructive CAD, coronary microvascular dysfunction was present in 54%, with the classical type being more prevalent than the endogen type.
Cross-Sectional (n=239)
No
Answers are grounded in this paper and cite their sources.
More than half of symptomatic patients with cardiometabolic risk factors but no obstructive CAD have coronary microvascular dysfunction, with distinct classical and endogen phenotypes that may necessitate tailored treatment approaches.
Background: (predominantly related to alterations in resting MBF) normal coronary microvascular function (nCMF) or coronary microvascular dysfunction (CMD) in a clinical population without flow-limiting obstructive CAD. Methods: N-ammonia PET/CT concurrently assessed myocardial flow reserve (MFR = MBF stress/MBF rest). Normal nCMF was defined by a MFR of ≥ 2.0, while an abnormal MFR of < 2.0 signified CMD. In addition, patients were subgrouped into classical and endogen type of nCMF and CMD, respectively. Results: In the whole study population, CMD was present in 54% (130/239). The classical type was more prevalent than the endogen type of CMD (65% vs 35%, p ≤ 0.008). The classical type of CMD was paralleled by a high prevalence of diabetes mellitus, metabolic syndrome, and obesity, while the endogen type of CMD was accompanied by a higher prevalence of arterial hypertension, obesity, and/or morbid obesity. Further, the classical type of nCMF was more frequently observed that the endogen type (74% vs. 26%, p ≤ 0.007). The endogen type of nCMF was related to lower heart rate and/or arterial blood pressures. Conclusions: In this contemporary clinical study population, slightly more than half of symptomatic patients had CMD with predominance of the classical type. These observations emphasize the need for standardized reporting of CMD to gear individualized and/or intensified medical treatment to improve symptoms and/or clinical outcome in these patients.
No takes yet. Share an insight, caveat, or question.
Bhandiwad et al. (2023) conducted a cross-sectional in Symptomatic patients with cardio-metabolic risk factors and a low likelihood of flow-limiting obstructive coronary artery disease (n=239). Coronary microvascular dysfunction (CMD) classical type vs. Coronary microvascular dysfunction (CMD) endogen type was evaluated on Prevalence of CMD types (classical vs. endogen) (p=≤ 0.008). In symptomatic patients without flow-limiting obstructive CAD, coronary microvascular dysfunction was present in 54%, with the classical type being more prevalent than the endogen type.
Synapse has enriched 10 related papers. Consider them for comparative context: